These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9373240

  • 1. In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.
    Dorfman DM, Schultze JL, Shahsafaei A, Michalak S, Gribben JG, Freeman GJ, Pinkus GS, Nadler LM.
    Blood; 1997 Dec 01; 90(11):4297-306. PubMed ID: 9373240
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D.
    Eur J Immunol; 1998 Jan 01; 28(1):90-103. PubMed ID: 9485189
    [Abstract] [Full Text] [Related]

  • 5. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL.
    Eur J Immunol; 1999 Aug 01; 29(8):2367-75. PubMed ID: 10458748
    [Abstract] [Full Text] [Related]

  • 6. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
    Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM.
    Blood; 1996 Jul 01; 88(1):41-8. PubMed ID: 8704200
    [Abstract] [Full Text] [Related]

  • 7. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT, Gessner A, Miller TP, Hersh EM, Johnson CS, Cui H, Frutiger Y, Grogan TM.
    Clin Cancer Res; 2000 Oct 01; 6(10):3904-9. PubMed ID: 11051236
    [Abstract] [Full Text] [Related]

  • 8. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW, Vandenberghe P, de Boer M, Ceuppens JL.
    Immunol Rev; 1996 Oct 01; 153():47-83. PubMed ID: 9010719
    [Abstract] [Full Text] [Related]

  • 9. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F, Csernok E, Wang G, Gross WL.
    Clin Exp Immunol; 1998 Oct 01; 114(1):113-8. PubMed ID: 9764612
    [Abstract] [Full Text] [Related]

  • 10. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L, Plumas J, Jacob MC, Bost F, Molens JP, Sotto JJ, Bensa JC.
    Exp Hematol; 1999 Mar 01; 27(3):479-88. PubMed ID: 10089910
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
    van Gool SW, Barcy S, Devos S, Vandenberghe P, Ceuppens JL, Thielemans K, de Boer M.
    Res Immunol; 1995 Mar 01; 146(3):183-96. PubMed ID: 8525052
    [No Abstract] [Full Text] [Related]

  • 13. Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice.
    Holländer GA, Castigli E, Kulbacki R, Su M, Burakoff SJ, Gutierrez-Ramos JC, Geha RS.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4994-8. PubMed ID: 8643517
    [Abstract] [Full Text] [Related]

  • 14. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.
    Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN.
    J Biol Chem; 2002 Mar 08; 277(10):7766-75. PubMed ID: 11726649
    [Abstract] [Full Text] [Related]

  • 15. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
    Otten HG, Bor B, Ververs C, Verdonck LF, De Boer M, De Gast GC.
    Immunology; 1996 Jun 08; 88(2):214-9. PubMed ID: 8690453
    [Abstract] [Full Text] [Related]

  • 16. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice.
    Van Parijs L, Sethna MP, Schweitzer AN, Borriello F, Sharpe AH, Abbas AK.
    J Immunol; 1997 Dec 01; 159(11):5336-44. PubMed ID: 9548473
    [Abstract] [Full Text] [Related]

  • 17. Costimulatory molecules (CD80 and CD86) on Reed-Sternberg cells are associated with the proliferation of background T cells in Hodgkin's disease.
    Nozawa Y, Wakasa H, Abe M.
    Pathol Int; 1998 Jan 01; 48(1):10-4. PubMed ID: 9589458
    [Abstract] [Full Text] [Related]

  • 18. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B, Nash MA, Lenzi R, Platsoucas CD, Freedman RS.
    Clin Exp Immunol; 2000 Jan 01; 119(1):19-27. PubMed ID: 10606960
    [Abstract] [Full Text] [Related]

  • 19. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA, Alegre ML, Thompson CB.
    J Immunol; 2000 Mar 15; 164(6):2987-93. PubMed ID: 10706686
    [Abstract] [Full Text] [Related]

  • 20. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ, Joost van Neerven RJ, Van Gool SW, Coorevits L, de Boer M, Ceuppens JL.
    Int Immunol; 1997 Aug 15; 9(8):1095-102. PubMed ID: 9263006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.